tiprankstipranks
Innoveren Scientific (IVRN)
OTHER OTC:IVRN
US Market
IVRN
Innoveren Scientific
RESEARCH TOOLSreports

Innoveren Scientific (IVRN) Financial Statements

12 Followers

Innoveren Scientific Financial Overview

Innoveren Scientific's market cap is currently $3.20K. The company's EPS TTM is $-5.751; its P/E ratio is ―; Innoveren Scientific is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Dec 21Dec 20Dec 19Dec 18
Income Statement
Total Revenue
Gross Profit$ 335.86K$ 906.81K$ 1.38M$ 6.29M$ 5.52M
Operating Income$ -5.11M$ -5.29M$ -7.09M$ -15.05M$ -3.60M
EBITDA$ -9.92M$ -4.61M$ -4.92M$ -28.52M$ -4.11M
Net Income$ -10.30M$ -4.80M$ -6.46M$ -29.81M$ -4.39M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 137.36K$ 321.40K$ 2.20M$ 3.27M$ 454.90K
Total Debt$ 3.92M$ 3.62M$ 1.17M$ 1.26M$ 5.00M
Net Debt$ 3.92M$ 3.52M$ -467.88K$ -165.19K$ 4.93M
Total Liabilities$ 9.49M$ 4.98M$ 3.25M$ 12.73M$ 6.49M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -1.91M$ -4.82M$ -7.26M$ -12.31M$ -3.57M
Operating Cash Flow$ -1.91M$ -4.81M$ -7.26M$ -12.29M$ -3.54M
Investing Cash Flow
Financing Cash Flow

Innoveren Scientific Earnings and Revenue History

Income Statement >

Innoveren Scientific Debt to Assets

Balance Sheet >

Innoveren Scientific Cash Flow

Cash Flow >

Innoveren Scientific Forecast EPS vs Actual EPS

Earnings >